Moran Mary
Executive Director, Policy Cures, Sydney, Australia.
PLoS Biol. 2016 Mar 2;14(3):e1002363. doi: 10.1371/journal.pbio.1002363. eCollection 2016 Mar.
The Global Health 2035 report notes that the "grand convergence"--closure of the infectious, maternal, and child mortality gap between rich and poor countries--is dependent on research and development (R&D) of new drugs, vaccines, diagnostics, and other health tools. However, this convergence (and the R&D underpinning it) will first require an even more fundamental convergence of the different worlds of public health and innovation, where a largely historical gap between global health experts and innovation experts is hindering achievement of the grand convergence in health.
《2035年全球健康报告》指出，“大趋同”——消除富国与穷国之间在传染病、孕产妇和儿童死亡率方面的差距——取决于新药、疫苗、诊断方法及其他卫生工具的研发。然而，这种趋同（以及作为其基础的研发）首先需要公共卫生和创新这两个不同领域实现更为根本的趋同，因为全球卫生专家与创新专家之间长期存在的差距正在阻碍实现健康领域的大趋同。
